NCT00782275View on ClinicalTrials.gov

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Renal Cell CarcinomaKidney Cancer
Interventions
DRUG

bevacizumab

DRUG

temsirolimus

Trial Locations (3)

37232

Vanderbilt Univeristy Medical Center, Nashville

02115

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Vanderbilt University Medical Center

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER